epigallocatechin gallate has been researched along with n,n-dimethylarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MF; Deng, PY; Hu, CP; Li, YJ; Tang, WJ | 1 |
| Chen, X; Li, J; Lv, L; Qiao, H; Zhang, Z; Zou, C | 1 |
2 other study(ies) available for epigallocatechin gallate and n,n-dimethylarginine
| Article | Year |
|---|---|
Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
Topics: Animals; Arginine; Catechin; Cells, Cultured; Cholesterol, LDL; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Male; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Vasodilation | 2006 |
(-)-Epigallocatechin Gallate Inhibits Asymmetric Dimethylarginine-Induced Injury in Human Brain Microvascular Endothelial Cells.
Topics: Antioxidants; Apoptosis; Arginine; Brain; Catechin; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Microvessels | 2016 |